Evogene and Verb Biotics Enter Collaboration Agreement to Advance Probiotic Innovation
The parties will identify and design probiotic bacteria that produce highly sustainable quantities of microbial metabolites, known to improve human
Read MoreThe parties will identify and design probiotic bacteria that produce highly sustainable quantities of microbial metabolites, known to improve human
Read More24 January 2024, Israel: Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. (Nasdaq: EVGN.TASE:
Read More19 January 2024, Israel: Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. (Nasdaq: EVGN,
Read More25 December 2023, Israel: Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. (Nasdaq:
Read MoreMr. Yoash Zohar, a seasoned ag executive, is joining Casterra as CEO to lead the company’s significant operational expansion 21
Read MoreThe agreement supports Lavie Bio’s 2024 sales growth plan for spring wheat, durum, and barley in Canada 06 December 2023, Israel: Lavie Bio Ltd.,
Read MoreLavie Bio will offer Yalos™ (formerly Thrivus™) to farmers growing spring wheat, durum and barley across the US and Canada
Read More16 November 2023, Israel: Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN), a leading computational biology company aiming to revolutionize the development of life-science-based products
Read More01 November 2023, Israel: Colors Farm Ltd, a cutting-edge company in sustainable aquaculture and biotech and Evogene Ltd. (“Evogene”) (NASDAQ: EVGN, TASE:
Read More18 October 2023, Israel: Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and
Read More